Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Abstract

URL: http://www.clinicaltrials.gov. Unique identifier: NCT02023879.